Mitsunori Kirihata - Search Results

Year	Number of Results
2002	2
2003	2
2004	1
2005	1
2006	2
2007	4
2008	4
2009	7
2011	5
2012	5
2013	2
2014	1
2015	3
2016	1
2017	3
2019	4
2020	4
2021	2
2022	3
2023	4
2024	0

1

Dodecaborate Conjugates Targeting Tumor Cell Overexpressing Translocator Protein for Boron Neutron Capture Therapy.

Hattori Y, Ishimura M, Ohta Y, Takenaka H, Kawabata S, Kirihata M. Hattori Y, et al. Among authors: kirihata m. ACS Med Chem Lett. 2021 Dec 1;13(1):50-54. doi: 10.1021/acsmedchemlett.1c00377. eCollection 2022 Jan 13. ACS Med Chem Lett. 2021. PMID: 35059123 Free PMC article.

2

Chemical structure of hydrolysates of cereulide and their time course profile.

Naka T, Takaki Y, Hattori Y, Takenaka H, Ohta Y, Kirihata M, Tanimori S. Naka T, et al. Among authors: kirihata m. Bioorg Med Chem Lett. 2020 May 1;30(9):127050. doi: 10.1016/j.bmcl.2020.127050. Epub 2020 Feb 22. Bioorg Med Chem Lett. 2020. PMID: 32143886

3

Synthesis and cytotoxicity of the boron carrier pentagamaboronon-0-ol for boron neutron capture therapy against breast cancer.

Utomo RY, Wulandari F, Novitasari D, Susidarti RA, Kirihata M, Hermawan A, Meiyanto E. Utomo RY, et al. Among authors: kirihata m. J Adv Pharm Technol Res. 2022 Jan-Mar;13(1):70-76. doi: 10.4103/japtr.japtr_220_21. Epub 2022 Jan 21. J Adv Pharm Technol Res. 2022. PMID: 35223445 Free PMC article.

4

Dodecaborate-Encapsulated Extracellular Vesicles with Modification of Cell-Penetrating Peptides for Enhancing Macropinocytotic Cellular Uptake and Biological Activity in Boron Neutron Capture Therapy.

Hirase S, Aoki A, Hattori Y, Morimoto K, Noguchi K, Fujii I, Takatani-Nakase T, Futaki S, Kirihata M, Nakase I. Hirase S, et al. Among authors: kirihata m. Mol Pharm. 2022 Apr 4;19(4):1135-1145. doi: 10.1021/acs.molpharmaceut.1c00882. Epub 2022 Mar 17. Mol Pharm. 2022. PMID: 35298163

5

Tumour-suppressive effects of curcumin analogs CCA-1.1 and Pentagamavunone-1 in colon cancer: In vivo and in vitro studies.

Wulandari F, Ikawati M, Widyarini S, Kirihata M, Novitasari D, Kato JY, Meiyanto E. Wulandari F, et al. Among authors: kirihata m. J Adv Pharm Technol Res. 2023 Oct-Dec;14(4):317-324. doi: 10.4103/JAPTR.JAPTR_315_23. Epub 2023 Oct 30. J Adv Pharm Technol Res. 2023. PMID: 38107450 Free PMC article.

6

Synthesis of the reported structure of homocereulide and its vacuolation assay.

Naka T, Hattori Y, Takenaka H, Ohta Y, Kirihata M, Tanimori S. Naka T, et al. Among authors: kirihata m. Bioorg Med Chem Lett. 2019 Mar 1;29(5):734-739. doi: 10.1016/j.bmcl.2019.01.007. Epub 2019 Jan 10. Bioorg Med Chem Lett. 2019. PMID: 30665680

7

The Evaluation of Cytotoxic Properties from CCB-2 Sugar Complexes Against TNBC and Non-TNBC Cells.

Jenie RI, Utomo RY, Susidarti RA, Novitasari D, Kirihata M, Meiyanto E. Jenie RI, et al. Among authors: kirihata m. Asian Pac J Cancer Prev. 2021 Jan 1;22(1):151-155. doi: 10.31557/APJCP.2021.22.1.151. Asian Pac J Cancer Prev. 2021. PMID: 33507693 Free PMC article.

8

Transcriptomics analyses reveal the effects of Pentagamaboronon-0-ol on PI3K/Akt and cell cycle of HER2+ breast cancer cells.

Hermawan A, Wulandari F, Yudi Utomo R, Asmah Susidarti R, Kirihata M, Meiyanto E. Hermawan A, et al. Among authors: kirihata m. Saudi Pharm J. 2023 Dec;31(12):101847. doi: 10.1016/j.jsps.2023.101847. Epub 2023 Oct 27. Saudi Pharm J. 2023. PMID: 38028209 Free PMC article.

9

Intracellular target delivery of cell-penetrating peptide-conjugated dodecaborate for boron neutron capture therapy (BNCT).

Nakase I , Katayama M , Hattori Y , Ishimura M , Inaura S , Fujiwara D , Takatani-Nakase T , Fujii I , Futaki S , Kirihata M . Nakase I , et al. Among authors: kirihata m. Chem Commun (Camb). 2019 Nov 19;55(93):13955-13958. doi: 10.1039/c9cc03924d. Chem Commun (Camb). 2019. PMID: 31617510

10

Cellular uptake evaluation of pentagamaboronon-0 (PGB-0) for boron neutron capture therapy (BNCT) against breast cancer cells.

Hermawan A, Susidarti RA, Ramadani RD, Qodria L, Utomo RY, Ishimura M, Hattori Y, Ohta Y, Kirihata M, Meiyanto E. Hermawan A, et al. Among authors: kirihata m. Invest New Drugs. 2019 Dec;37(6):1292-1299. doi: 10.1007/s10637-019-00765-9. Epub 2019 Mar 30. Invest New Drugs. 2019. PMID: 30929158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

54 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year